Etravirine
- TRADE NAME: Intelence (Tibotec)
- INDICATIONS: HIV infection
- CLASS: Non-nucleoside reverse transcriptase inhibitor
- HALF-LIFE: 41 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Atazanavir, Atorvastatin, Carbamazepine, Clarithromycin, Clopidogrel, Darunavir, Delavirdine, Digoxin, Doravirine, Efavirenz, Fosamprenavir, Ibrexafungerp, Indinavir, Lemborexant, Lumateperone, Maraviroc, Nelfinavir, Neratinib, Nevirapine, Non-nucleoside reverse transcriptase inhibitors, Olaparib, Palbociclib, Phenobarbital, Phenytoin, Rifabutin, Rifampin, Rifapentine, Rilpivirine, Ritonavir, Sildenafil, Simeprevir, St John's Wort, Tadalafil, Telithromycin, Tipranavir, Vardenafil, Venetoclax, Voriconazole
PREGNANCY CATEGORY: B
Please login to see the rest of this drug profile
SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
NEUROMUSCULAR/SKELETAL.
OCULAR.
RENAL.
RESPIRATORY.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric